AU1916501A - Oncolytic combinations for the treatment of cancer - Google Patents
Oncolytic combinations for the treatment of cancerInfo
- Publication number
- AU1916501A AU1916501A AU19165/01A AU1916501A AU1916501A AU 1916501 A AU1916501 A AU 1916501A AU 19165/01 A AU19165/01 A AU 19165/01A AU 1916501 A AU1916501 A AU 1916501A AU 1916501 A AU1916501 A AU 1916501A
- Authority
- AU
- Australia
- Prior art keywords
- cancer
- treatment
- oncolytic
- combinations
- oncolytic combinations
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16470499P | 1999-11-11 | 1999-11-11 | |
US60164704 | 1999-11-11 | ||
PCT/US2000/030839 WO2001034197A2 (en) | 1999-11-11 | 2000-11-09 | Oncolytic combinations for the treatment of cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1916501A true AU1916501A (en) | 2001-06-06 |
Family
ID=22595710
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU19165/01A Abandoned AU1916501A (en) | 1999-11-11 | 2000-11-09 | Oncolytic combinations for the treatment of cancer |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU1916501A (en) |
WO (1) | WO2001034197A2 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU1916601A (en) * | 1999-11-11 | 2001-06-06 | Eli Lilly And Company | Oncolytic combinations for the treatment of cancer |
JP2001247459A (en) | 2000-03-03 | 2001-09-11 | Oakland Uniservices Ltd | Combination therapy for cancer |
JP2003532675A (en) * | 2000-05-09 | 2003-11-05 | クレイトン ユニバーシティ | A method for inhibiting cancer cell growth and inducing its apoptosis |
WO2002009700A1 (en) | 2000-07-28 | 2002-02-07 | Cancer Research Technology Limited | Cancer treatment by combination therapy |
GB0121285D0 (en) | 2001-09-03 | 2001-10-24 | Cancer Res Ventures Ltd | Anti-cancer combinations |
GB2386836B (en) | 2002-03-22 | 2006-07-26 | Cancer Res Ventures Ltd | Anti-cancer combinations |
GB2394658A (en) | 2002-11-01 | 2004-05-05 | Cancer Rec Tech Ltd | Oral anti-cancer composition |
AU2007307597A1 (en) | 2006-10-12 | 2008-04-17 | Institute Of Medicinal Molecular Design. Inc. | Carboxylic acid derivatives |
US8633245B2 (en) | 2008-04-11 | 2014-01-21 | Institute Of Medicinal Molecular Design, Inc. | PAI-1 inhibitor |
CN110803987B (en) * | 2019-11-07 | 2022-10-14 | 苏州开元民生科技股份有限公司 | Preparation method of R- (+) -2- (4-hydroxyphenoxy) propionic acid |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2116324T3 (en) * | 1991-11-25 | 1998-07-16 | Lilly Co Eli | LEUCOTRENE ANTAGONISTS REPLACED WITH PHENYLPHENOL. |
WO1996006604A2 (en) * | 1994-08-31 | 1996-03-07 | Eli Lilly And Company | Methods for identifying and treating resistant tumors |
US5543428A (en) * | 1994-08-31 | 1996-08-06 | Eli Lilly And Company | Method for treating resistant tumors |
HUP9904672A2 (en) * | 1997-03-21 | 2000-05-28 | Eli Lilly And Co. | Leukotriene antagonists for oral squamous cell carcinoma |
WO2001034135A2 (en) * | 1999-11-11 | 2001-05-17 | Eli Lilly And Company | Oncolytic combinations for the treatment of cancer |
CN1390139A (en) * | 1999-11-11 | 2003-01-08 | 伊莱利利公司 | Oncolytic combinations for the treatment of cancer |
-
2000
- 2000-11-09 AU AU19165/01A patent/AU1916501A/en not_active Abandoned
- 2000-11-09 WO PCT/US2000/030839 patent/WO2001034197A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2001034197A3 (en) | 2002-05-10 |
WO2001034197A2 (en) | 2001-05-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2020501A (en) | Chemotherapy treatment | |
AU1958897A (en) | Egf-genistein conjugates for the treatment of cancer | |
AU2003200740A1 (en) | Compositions and methods for the treatment of tumor | |
AU2003200731A1 (en) | Compositions and methods for the treatment of tumor | |
AU2003200722A1 (en) | Compositions and methods for the treatment of tumor | |
AU2495200A (en) | Compositions and methods for the treatment of tumor | |
AU3791601A (en) | Treatment of coal | |
EP1176964B8 (en) | Uses of et743 for treating cancer | |
IL148579A0 (en) | Oncolytic combinations for the treatment of cancer | |
AU5089400A (en) | Arthritis treatment | |
AU2000258650A1 (en) | 2-piperidone compounds for the treatment of cancer | |
AU1916601A (en) | Oncolytic combinations for the treatment of cancer | |
AU6062900A (en) | Substituted indole compounds and their use for the treatment of cancer | |
AU1916501A (en) | Oncolytic combinations for the treatment of cancer | |
AU5547000A (en) | Novel treatment | |
AU7363000A (en) | Method for reducing the risk of cancer | |
AU1917101A (en) | Oncolytic combinations for the treatment of cancer | |
AU1595001A (en) | Oncolytic combinations for the treatment of cancer | |
AU4556800A (en) | Novel treatment | |
AU7636800A (en) | Improved ricin-like toxins for treatment of cancer | |
AU1595101A (en) | Oncolytic combinations for the treatment of cancer | |
AUPQ367699A0 (en) | Treatment of cancer | |
AU5552400A (en) | Treatment of cancer | |
AU2001257325A1 (en) | Cancer treatment | |
AU1592901A (en) | Oncolytic combinations for the treatment of cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |